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Abstract
The conversion of white adipose to the highly thermogenic beige adipose tissue has been proposed as a potential strategy
to counter the unfavorable consequences of obesity. Three regulators of this conversion have recently emerged but
information regarding their control is limited, and contradictory. We present two studies examining the control of these
regulators. Study 1: In 10 young men, the plasma concentrations of irisin and fibroblast growth factor 21 (FGF21) were
determined prior to and during activation of the sympathetic nervous system via hypoxic gas breathing (FIO2 = 0.11). The
measurements were performed twice, once with and once without prior/concurrent sympathetic inhibition via transdermal
clonidine administration. FGF21 was unaffected by basal sympathetic inhibition (3386113 vs. 295680 pg/mL; P = 0.43;
mean6SE), but was increased during hypoxia mediated sympathetic activation (3686135); this response was abrogated
(P = 0.035) with clonidine (269693). Irisin was unaffected by sympathetic inhibition and/or hypoxia (P.0.21). Study 2: The
plasma concentration of irisin and FGF21, and the skeletal muscle protein content of fibronectin type III domain containing
5 (FNDC5) was determined in 19 young adults prior to and following three weeks of sprint interval training (SIT). SIT
decreased FGF21 (338678 vs. 251636; P = 0.046) but did not affect FNDC5 (P = 0.79). Irisin was decreased in males (127618
vs. 90623 ng/mL; P = 0.045) and increased in females (139614 vs. 170618). Collectively, these data suggest a potential
regulatory role of acute sympathetic activation pertaining to the browning of white adipose; further, there appears to be a
sexual dimorphic response of irisin to SIT.
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Introduction
The conversion of white adipose tissue to the highly thermo-
genic beige adipose tissue has been identified as a potential
strategy to counter the unfavorable consequences of obesity in
adult humans [1–3]. Two regulators of this conversion have
recently been described but information regarding their control is
limited, and somewhat contradictory. Fibroblast growth factor 21
(FGF21) is released from the liver, white adipose tissue, and brown
adipose tissue [4,5], and is favorably associated with increased
insulin sensitivity and protection from weight gain [6–9]. Similarly,
irisin, the circulating product of the membrane bound protein,
fibronectin type III domain containing 5 (FNDC5) found
predominantly in skeletal muscle but also in white adipose tissue
[4,5,10,11]; is also positively related to insulin sensitivity and
weight loss [10]. Both FGF21and irisin/FNDC5 have been
mechanistically linked to the conversion of white to beige adipose
tissue [5,10].
In light of the potential clinical significance of FGF21 and
irisin/FNDC5 for the treatment of obesity, an understanding of
their regulation is of obvious importance. In this regard, we have
considered two potential regulators/perturbations that are not
necessarily mutually exclusive: the sympathetic nervous system
and sprint interval exercise training. Stimulation of sympathetic
activity via cold exposure is a well-known activator of beige fat in
humans [3,12–14]. There is some evidence from experimental
animals suggesting that the sympathetic nervous system may also
have a direct regulatory role pertaining to FGF21 [4,5], and
indirectly to irisin/FNDC5 via stimulation of peroxisome pro-
liferator-activated receptor gamma co-activator 1-alpha (PGC-1a;
[15]). Further, exercise, perhaps via intermittent increased
sympathetic activation, may also stimulate FGF21 and/or irisin/
FNDC5, although the evidence is somewhat contradictory
depending on species and type of exercise [10,16–18].
In the current manuscript we present two studies. Study 1 is a
retrospective analysis of plasma collected during a previously
published study [19]; we address the new hypothesis that the
sympathetic nervous system is an important physiological regula-
tor of FGF21 and irisin in adult males. In Study 2 we performed a
prospective investigation in which we examined the hypothesis
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that short-term sprint interval training would increase skeletal
muscle FNDC5 protein content, and increase circulating concen-
trations of irisin and FGF21 in adult males and females.
Methods
Research Participants – Studies 1 and 2
The experimental protocols conformed to the standards set by
the Declaration of Helsinki of 1975, as revised in 1983, and were
approved by the Institutional Review Board at Colorado State
University. The nature, purpose and risks of each study were
explained to research participants before written informed consent
was obtained. Select physiological characteristics of research
participants from each study are presented in Table 1. One
participant from Study 1 participated in Study 2.
Procedures Common to Both Studies - Screening
Body composition was assessed using dual-energy x-ray
absorptiometry (DXA-IQ; Lunar Radiation Corp., Madison,
WI, software v. 4.1). Maximal oxygen uptake (VO2max) was
determined with a metabolic cart (Parvo Medics, Sandy, UT)
during incremental cycle ergometer or treadmill exercise to
volitional fatigue, as previously described [20].
Study 1 – Influence of the sympathetic nervous system
on circulating FGF21 and irisin
Study 1 represents a retrospective analysis of plasma collected
during a previously published study [19], the focus of which was
insulin sensitivity, hypoxia and the sympathetic nervous system.
Following screening, research participants (young, healthy adult
males) reported to the laboratory on two separate occasions,
following an overnight fast and 48-hour abstention from vigorous
physical activity. On arrival participants were instrumented for
measurement of heart rate, blood pressure, and oxyhemoglobin
saturation (pulse oximeter; Cardiocap 5, GE Datex-Ohmeda,
Madison, WI, USA) and a catheter was inserted into a dorsal hand
vein for subsequent blood sampling. Following a brief period of
quiet rest in a semi-recumbent position, blood (15 ml) was sampled
and heart rate, blood pressure, and oxyhemoglobin saturation
were recorded. To activate the sympathetic nervous system,
research participants began breathing a hypoxic gas mixture
(FIO2 = 0.11, balance Nitrogen). After 15 minutes, blood was
sampled again and heart rate, blood pressure, and oxyhemoglobin
saturation were re-recorded.
To determine the influence of basal sympathetic activity on
circulating FGF21 and irisin, 48-hours prior to one of visits
(random order) transdermal clonidine administration (Catapres-
TTS; 0.2 mg/day) was initiated and continued for the duration of
that visit. Clonidine is a blood pressure medication; the
mechanism of action is via pre-junctional stimulation of alpha-2-
adrenergic receptors. We, and others, have previously demon-
strated that short-term clonidine use (2-to-7 days) results in
centrally mediated peripheral sympathetic inhibition, as reflected
by decreased plasma norepinephrine concentration and release,
and attenuated skeletal muscle sympathetic nerve activity [21,22].
Blood was divided equally into two, pre-chilled tubes, contain-
ing either K3-ethylenediaminetetraacetic acid (EDTA) or ethylene
glycol tetraacetic acid/glutathione. Within 60 minutes of collec-
tion blood was centrifuged to isolate plasma that was subsequently
stored at 280uC until analysis. Plasma concentrations of FGF21
(BioVender, Ashville, NC, USA), irisin (Phoenix Pharmaceutical,
Burlingame, CA, USA), and catecholamines (Rocky Mountain
Diagnostics, Colorado Springs, CO, USA) were measured using
enzyme-linked immunosorbent assays (ELISA).
Study 2 - Influence of short-term sprint interval training
on skeletal muscle FNDC5 protein content and
circulating FGF21 and irisin
Following screening research participants (young healthy adult
males and females) completed nine sessions of sprint interval
training over three weeks. Each session consisted of between four
and eight, 30-second bouts of ‘‘all-out’’ maximal efforts separated
by four minutes of recovery; to facilitate recuperation, each session
was separated by one to two days.
To document the effectiveness of the sprint interval training,
participants completed a time-to-exhaustion trial prior to and
following the nine sessions. These trials consisted of a 15-minute
low-intensity warm-up that transitioned into exercise at 80% of
pre-training VO2max (confirmed with indirect calorimetry at 5-
minutes) until exhaustion. Exhaustion was defined as an inability
to maintain the required external power output and/or volitional
exercise cessation. Prior to the pre-training time to exhaustion
trial, all research participants completed an identical trial for
purposes of habituation. During all of these trials, time cues were
obscured from the participants’ field of vision.
Skeletal muscle and venous blood samples were collected prior
to and following sprint interval training, after a 12-hour fast and
48-hour abstention from exercise. Skeletal muscle biopsies of the
vastus lateralis were obtained under local anesthesia (1% lidocaine)
using Bergstrom needles. Samples were flash frozen and stored at
280uC for further analysis. Skeletal muscle homogenates were
obtained from powderized tissue samples lysed with phosphatase
and protease inhibitors (HALT). All samples were standardized by
total protein and analyzed by SDS-PAGE. Tissue FNDC5 (Abcam
(ab93373), Cambridge, MA, USA) was determined by western
blotting. Plasma concentrations of FGF21 and irisin were analyzed
following the procedures described in Study 1. In light of previous
reports of associations between insulin sensitivity and FGF21 and
irisin, pre-training circulating concentrations of glucose and insulin
were determined and used to calculate a value for homeostatic
model assessment of insulin resistance (HOMA-IR: fasting glucose
(mmol/L) 6 fasting insulin (mU/L)/22.5). Glucose concentration
was analyzed immediately (from ,1 ml whole blood) using an
automated device (2300 STAT Plus Glucose Lactate Analyzer,
YSI Inc., Yellow Springs, Ohio, USA) and insulin concentration
via ELISA (ALPCO Diagnostics, Salem, NH, USA). In addition,
our laboratory has an interest in the adipokine, pigment
epithelium derived factor (PEDF), a physiological determinant of
insulin sensitivity, oxidative stress and inflammation [19–21,23].
Plasma PEDF concentration was also determined via ELISA
(Millipore Corporation, Billerica, MA, USA).
Table 1. Selected baseline physical characteristics of research
participants.
Study 1 Study 2
Sex (M/F) 10/0 7/12
Age (years) 2361 2461
Body mass index (kg/m2) 24.260.8 26.861.1
% Body Fat 18.561.2 33.761.5
VO2max (ml/kg/min) 46.862.5 35.461.5
Data are mean 6 SE. VO2max: Maximal oxygen consumption.
doi:10.1371/journal.pone.0090696.t001
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Statistical Analysis
These were controlled, repeated measures studies. Accordingly,
main effects of, and interactions between, hypoxia and sympa-
thetic inhibition, and sprint interval training and sex were
examined via two-way repeated measures analysis of variance
(ANOVA). Multiple comparisons of factor means were performed
using the Newman-Keuls test. Paired sample t-tests were used to
assess delta values for FGF21 and irisin. Pearson correlations were
used to investigate relationships between the dependent variables
and potential modifiers. The level of statistical significance was set
at P,0.05. Data are expressed as mean 6 SE.
Results
Study 1 – Influence of the sympathetic nervous system
on circulating FGF21 and irisin
Clonidine decreased basal sympathetic activity, as indicated by
decreases in circulating plasma norepinephrine (20%) and
epinephrine (38%; Figure 1), and indirectly by decreases in heart
rate (P = 0.001; Table 2) and diastolic blood pressure (P = 0.041;
Table 2). This decrease in basal sympathetic activity was not
accompanied by a change in plasma FGF21 (P = 0.434) or irisin
(P = 0.418), suggesting that basal sympathetic activity does not
contribute to the regulation of either variable.
Hypoxia decreased resting oxyhemoglobin saturation from
96.760.4 to 62.062.1% (P,0.001); clonidine did not influence
this response (P = 0.44). Hypoxia also dramatically increased
sympathetic activity, as represented by 2-3-fold increases in
circulating plasma norepinephrine and epinephrine (both
P,0.001; Figure 1); and appreciable increases in heart rate and
systolic blood pressure (Table 2). FGF21 was unaffected by basal
sympathetic inhibition (3386113 vs. 295680 pg/mL; P = 0.433),
but was increased during hypoxia mediated sympathetic activation
(3686135 pg/mL); this response was abrogated (Figure 2;
P = 0.035) with clonidine (269693 pg/mL), suggesting that
plasma FGF21 responds to acute increased signaling from the
sympathetic nervous system. Noteworthy, the hypoxia-mediated
increase in plasma epinephrine was positively associated with the
magnitude of increase in FGF21 (r = 0.90, P = 0.04). Irisin did not
respond to the hypoxia-mediated increase in sympathetic activa-
tion; clonidine did not interact with this response (P = 0.438;
Figure 2).
Study 2 - Influence of short-term sprint interval training
on skeletal muscle FNDC5 protein content and
circulating FGF21 and irisin
Sprint interval training increased time to exhaustion (from
38.764.4 to 49.367.4 minutes, P = 0.048; Figure 3A) providing
evidence that the exercise regimen was a physiologically significant
intervention. Contrary to our hypothesis, sprint training decreased
circulating FGF21 (P = 0.046; Figure 3B). Skeletal muscle FNDC5
protein content and plasma irisin were unaffected (both P.0.787)
by sprint interval training.
In contrast to Study 1, Study 2 consisted of both male and
female research participants, thus we were able to preliminary
exploration of potential sex differences. With respect to the
influence of sprint interval training on time to exhaustion, there
was neither a main effect of sex (P = 0.793) nor an interaction
between sex and training (P = 0.587), suggesting that males and
females benefitted similarly from the exercise regimen. Consistent
with this observation, the decrease in plasma FGF21 with sprint
interval training was not sex-dependent (main effect of sex:
P = 0.386; sex-training interaction: P = 0.894). Further, the lack of
influence of sprint training on skeletal muscle FNDC5 protein was
consistent between sexes (main effect of sex: P = 0.157; sex-training
interaction: P = 0.629). Unexpectedly, there was a sex-training
Figure 1. Circulating catecholamine response to hypoxia and
clonidine. Plasma norepinephrine (A) and epinephrine (B) in response
to normoxic (FIO2 = 0.21) and hypoxic gas (FIO2 = 0.11) breathing with
and without concomitant sympathetic inhibition (48-h transdermal
administration of the centrally acting a2-adrenergic receptor agonist
clonidine). Data are mean 6 SE. Hypoxic gas breathing increased
norepinephrine (P = 0.001) and epinephrine (P,0.001). Clonidine
attenuated the rise in norepinephrine (P = 0.014) and epinephrine
(P = 0.061).
doi:10.1371/journal.pone.0090696.g001
Table 2. Hemodynamic responses to hypoxia with and
without clonidine.
Normoxia Normoxia Hypoxia Hypoxia
Placebo Clonidine Placebo Clonidine
HR 5762 4963* 8366++ 7164** +
SBP 12363 11363 12665 12065
DBP 7563 6662* 7463 6864
Data are mean 6 SE. HR: Heart rate. SBP: Systolic blood pressure. DBP: Diastolic
blood pressure. *P,0.05 compared to Normoxia – Placebo. **P = 0.061
compared to Hypoxia – Placebo. +P,0.001 compared to Normoxia – Clonidine.
++P = 0.001 compared to Normoxia – Placebo.
doi:10.1371/journal.pone.0090696.t002
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interaction for plasma irisin concentration (P = 0.012). Sprint
interval training increased plasma irisin concentration in females
and decreased it in males (Figure 3D). To further illustrate this
sexual dimorphism, while there were no sex differences in plasma
irisin at baseline, following sprint training circulating irisin was
greater in females compared with males (P = 0.001).
To advance the exploration of the associations between these
regulators of white adipose browning and indices of insulin
resistance, the relations between FGF21, irisin and FNDC5 and
fasting glucose, insulin, HOMA-IR and PEDF were examined.
None of these relations were significant (all P.0.223) with the
exception of an inverse relation between irisin and PEDF
(r = 20.46, P = 0.047).
Discussion
FGF21 and irisin/FNDC5 have been mechanistically linked to
the conversion of white adipose to thermogenic beige adipose
tissue [5,10], however the physiological control of these regulators
is both important to clarify and, at the moment, poorly
understood. The novel findings of this manuscript are: 1) basal
sympathetic activity does not influence circulating FGF21 or irisin;
2) FGF21 is increased in response to acute sympathetic activation;
3) sprint interval training decreases FGF21, does not affect skeletal
muscle FNDC5, and results in a sexual dimorphic response in
systemic irisin (reduced in males and increased in females).
The sympathetic nervous system is a well-known activator of
beige (brown) adipose in adult humans. Combined use of positron
emission tomography and computed tomography (PET/CT)
scanning during administration of fluorodeoxyglucose (18F) is
currently the gold standard non-invasive method of quantifying
beige fat activation [24]; b-adrenergic receptor blockade decreases
the metabolic activity of beige fat, thus rendering its detection
extremely difficult [25]. It seems plausible that the sympathetic
nervous system may also contribute to the regulation of FGF21
and/or irisin/FNDC5 as part of the coordinated control of the
‘‘browning’’ of adipocytes. Data from cell and animal studies
support this notion. Administration of a non-selective b-adrenergic
receptor agonist increases FGF21 mRNA and secretion [4,5] in
rodents, and b3-adrenergic receptor stimulation increases FGF21
gene expression in the white and brown adipose tissue of mice [5].
In humans, 60 minutes following acute exercise, and presumably
acute sympathetic activation, circulating FGF21 is increased [16].
Further, acute exercise is a powerful stimulator of skeletal muscle
PGC1-a [26,27], mediated in part by sympathetic activation [28],
and downstream targets of PGC1-a include FNDC5 and
subsequently irisin [10]. Accordingly, we directly assessed the
influence of tonic sympathetic activity and the responses to acute
sympathetic activation of circulating FGF21 and irisin in adult
men. Decreasing basal sympathetic activity did not influence
FGF21 or irisin, however, consistent with cell and animal studies,
Figure 2. Sympathetic nervous system control of brown fat
regulators. Change in plasma fibroblast growth factor 21 (FGF21) (A)
and irisin (B) from normoxia (FIO2 = 0.21) to hypoxia (FIO2 = 0.11) with
and without prior/concurrent sympathetic inhibition (48-hr transdermal
administration of the centrally acting a2-adrenergic receptor agonist
clonidine). Data are mean 6 SE. * P = 0.035 compared to clonidine.
doi:10.1371/journal.pone.0090696.g002
Figure 3. Effect of sprint interval training on exercise
performance and brown fat regulators. Time to exhaustion (A),
plasma fibroblast growth factor 21 (FGF21) (B), fibronectin type III
domain containing 5 (FNDC5) protein expression (C), and plasma irisin
(D) prior to (Pre-SIT) and following (Post-SIT) three weeks of sprint
interval training (SIT). Data are mean 6 SE * P,0.05 compared to Pre-
SIT. + P = 0.001 compared to males Post-SIT.
doi:10.1371/journal.pone.0090696.g003
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FGF21 increased in response to acute sympathetic activation.
Noteworthy, the magnitude of increase in circulating FGF21 was
positively related to the magnitude of increase in circulating
epinephrine. Peroxisome proliferator-activated receptor alpha
(PPARa) in the liver and PPARc in white adipose tissue are both
activators of FGF21 [29–32], and, in turn, both will respond to the
increase in free fatty acids resulting from sympathetically mediated
lipolysis [33]. It is plausible that the increase in FGF21 we report
was due to sympathetic activation and the subsequent lipolysis.
From a teleological perspective, weight (fat) gain is associated with
increased sympathetic activity [34–39], usually accompanied by
increased b-adrenergic receptor mediated energy expenditure [40]
to defend body composition. It seems feasible, at least initially (that
is, before obesity associated b-adrenergic receptor dysfunction
[41–43]), this increased sympathetic drive may also be targeting
activation and formation of thermogenic adipose tissue.
We surmised that sympathetic activation may also contribute, at
least in part, to the previously reported responses of FGF21 and
irisin/FNDC5 to exercise training. This was based on previous
studies reporting increases in all of these potential regulators
following either acute or short-term exercise training in animals
[10,16] and humans [10,16–18]. Sprint-interval training is a low-
volume, high-intensity alternative to traditional, endurance
exercise training. It has been shown repeatedly to evoke favorable
and significant physiological adaptations that have positive
implications for both health (cardiovascular and metabolic) and
athletic performance [20,44–47]. While sympathetic activation
following sprint-interval training was not assessed in the current
study, previous studies in humans confirm that sprint exercise
activates the sympathetic nervous system [48]. In the current
study, sprint interval training decreased circulating FGF21 and did
not affect skeletal muscle FNDC5 protein content. However,
circulating irisin was decreased in males and increased in females.
To our knowledge, this is the first investigation to report on the
influence of exercise training on FNDC5 protein content in
human skeletal muscle. Ten weeks of endurance exercise increased
FNDC5 mRNA [10] in obese men while FNDC5 mRNA did not
change following 21 weeks of endurance exercise in normal weight
men [49]. In animal models, exercise training increased FNDC5
mRNA in mice [10], but decreased FNDC5 mRNA and protein
content in pigs [50]. In C2C12 myotubes, administration of
AICAR, an exercise mimetic, decreased FNDC5 mRNA [51].
These discrepancies may be due to species differences, variations
in exercise intensity and/or duration of exercise training, timing of
tissue collection with respect to the most recent exercise bout, and/
or kinetic differences between the mRNA and protein responses to
exercise. A definitive explanation is beyond the scope of the
current study.
Contrary to our hypothesis, circulating FGF21 was decreased
following sprint interval training. In adult humans, previous
studies have demonstrated increased circulating FGF21 following
single bouts of exercise [16], greater magnitudes of increase in
FGF21 following higher intensity exercise (80 vs. 50% VO2max)
[16], and increased FGF21 after short-term (2-weeks) of
incremental treadmill exercise [18]. In the acute exercise studies,
blood was sampled one hour following exercise completion, and in
the training study within 24-hours of the final exercise session.
Recently, the half-life of FGF21 has been established as less than
two hours in humans [52]. In the present study, blood was
sampled 48-hours after the final exercise bout; thus discrepancies
between the present and previous studies may be attributable to
FGF21’s short half-life and/or the duration for which its secretion
was increased. An additional consideration pertaining to the
FGF21 response to exercise training is the response of its co-factor,
b-Klotho. b-Klotho is a member of the Klotho family of
transmembrane proteins, is present in FGF21 target tissues, and
is thought to be required for FGF21 mediated metabolic effects
[53,54]. Bidirectional FGF21 and b-Klotho responses to exercise
and caloric restriction (that is, decreased FGF21 and increased b–
Klotho) have been reported [55]; these responses were thought to
mediate protection from obesity and obesity-induced nonalcoholic
fatty liver disease in rats. Clearly the responses of, and interactions
with, FGF21 to exercise training, including sprint interval training,
are complex, and single time point studies may be inadequate to
fully describe this physiology.
Another novel finding of the present study was the sexual
dimorphic response of circulating irisin to sprint interval training.
Recent studies have reported no change in circulating irisin
following aerobic and strength training programs [49,56,57] and
there were no differences in the responses to training between
males and females [56]. Explanations for this current sex
difference are potentially related to differences in the transcrip-
tion/translation of FNDC5 and/or the regulation of the cleavage,
secretion, and/or clearance of irisin. Potential contributors include
differences in body composition, variability in other adaptations to
sprint interval training (such as exercise tolerance), and the
influence of circulating sex hormones. With respect to body
composition, large population studies that have included adults
spanning a wide range of body composition (anorexia through to
obesity) have reported positive relations between circulating irisin
and fat free mass [17,58]. In the present study, fat free mass was
lower in females compared with males but there was no relation
between fat free mass (or any other index of body composition)
and circulating irisin (data not shown). Relative to these other
studies, our research participants comprised a smaller and
relatively homogenous population; this may explain the non-
significant associations. With respect to the influence of sprint
interval training on exercise tolerance, there was neither a main
effect of sex nor an interaction between sex and training,
suggesting that males and females benefitted similarly, at least
from an athletic performance perspective, from the exercise
regimen. Finally, we did not attempt to time standardize data
collection relative to menstrual phase. This decision was based on
the hypothesis that the accumulative influence of sprint interval
training would be greater than the influence of circulating sex
hormones. Further, a sex hormone mediated explanation for the
sexual dimorphic irisin response to sprint interval training seems
unlikely as presumably the sex hormonal profile in the female
participants would have been highly variable on account of the
absence of menstrual phase standardized data collection. Thus,
that a sexual dimorphic response was identified against the
background of highly variable circulating sex hormone concen-
trations speaks to the strength of the dimorphic response.
Circulating irisin and FGF21 have been linked statistically with
indices of insulin resistance [6–10,59]. No significant relationships
were discovered at baseline or post-sprint interval training among
primary outcome variables and glucose, insulin, or HOMA-IR.
Again, this may be reflective of the relatively homogenous study
population coupled with the good health status of the research
participants. We report for the first time on the inverse association
between irisin and PEDF. This inverse association is consistent
with the current understanding of the respective roles of PEDF
and irisin on insulin sensitivity [20,60]. Whether the relation
between these two variables is independent of co-variables remains
to be seen.
There are a few additional issues pertaining to these studies that
warrant brief discussion. The first pertains to our choice of
hypoxia as a method of evoking a sympathetic response.
FGF21 & Irisin: SNS Control & Exercise Effect
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Alternatives to hypoxia include cold exposure, pharmacological
manipulation (adrenergic agonists), and/or exercise. Cold expo-
sure is already known to increase the thermogenic behavior of
brown adipose in humans [3,13,14,61], thus we chose a
sympathetic activator not previously associated with brown
adipose behavior. To inhibit basal sympathetic activation we
chose clonidine. Use of hypoxia to activate the sympathetic
nervous system avoided the possibility of potentially unfavorable
pharmacological interactions. While exercise is a powerful
sympathetic stimulator it evokes many other physiological
responses making definitive interpretation as to control of irisin
and FGF21 problematic. Of course, acute hypoxia is not without
its own side effects, including inflammation and oxidative stress,
however the fact that sympathetic inhibition with clonidine
diminished the influence of hypoxia on the primary outcomes
suggests that hypoxia per se, is not a significant controller. Next,
the research participants in the current studies comprised young,
healthy, non-obese adults. Obesity is known to modify/inhibit
skeletal muscle and adipose function, thus it is possible that obese
adults may not have responded in the same way (magnitude and/
or direction) to the stimuli described herein. However, if one
considers the law of initial baseline, then one might speculate that
adults with low basal FGF21 and irisin/FNDC5 may have greater
opportunity for improvement (that is, they will not be limited by a
ceiling effect). Clearly a prospective empirical study would provide
the most insight into this issue. Another potential limitation is the
absence of a sedentary/time control condition in Study 2, the
sprint interval training study. It is possible that the observed
responses with respect to our primary outcome variables could be
attributed to external factors. We think this is unlikely as there is
no reason to suspect any of the variables would have changed;
however, the limitation is acknowledged. Finally, the decision to
investigate sex differences in study 2 was made a posteriori.
Accordingly, the design was potentially underpowered to discern
differences between males and females in FGF21 and FNDC5.
However, this speaks to the strength of the discovery of the sexual
dimorphic response of irisin to sprint training.
In summary, the conversion of white adipose tissue to the highly
thermogenic beige adipose tissue in adult humans has been
proposed as a potential treatment for global obesity [1–3]. Three
regulators of this conversion have recently been described but
information regarding their control is limited, and somewhat
contradictory. Our data suggest while basal sympathetic activity
does not influence circulating FGF21 or irisin, FGF21 is increased
in response to acute sympathetic activation. Also, although sprint
interval training does not affect skeletal muscle FNDC5 protein
content, it does decrease circulating FGF21 and has opposing
effects on circulating irisin in males and females.
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